(Q46412365)

22 December 2017

title

Fatal outcome of nevirapine-associated toxic epidermal necrolysis (English)

1 reference

22 December 2017

author name string

K Leng

series ordinal

1

1 reference

22 December 2017

A Lonsdorf

series ordinal

2

1 reference

22 December 2017

M Hartmann

series ordinal

3

1 reference

22 December 2017

publication date

1 September 2008

1 reference

22 December 2017

International Journal of STD & AIDS

published in

1 reference

22 December 2017

volume

19

1 reference

22 December 2017

issue

9

1 reference

22 December 2017

page(s)

642-643

1 reference

22 December 2017

Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

cites work

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008062

Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008062

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008062

Severe cutaneous reactions associated with the use of human immunodeficiency virus medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008062

Stevens-Johnson syndrome caused by the antiretroviral drug nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008062

Identification of abacavir hypersensitivity reaction in health care claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008062

21 January 2018

Identifiers

DOI

10.1258/IJSA.2008.008062

1 reference

22 December 2017

PubMed ID

18725560

1 reference

22 December 2017